Please login to the form below

Not currently logged in
Email:
Password:

New EMG leadership announced

The European Medicines Group has elected Matthew Speers as chair and Steve Turley as vice chair

Matthew Speers has been elected chair of the European Medicines Group (EMG), which represents the UK voice of research-driven pharmaceutical companies headquartered in continental Europe.

Speers is managing director of UCB UK and Ireland, a position he has held since March 2008. In his new capacity as chair, Speers will be supported by Steve Turley, managing director, Lundbeck, who was elected vice chair.

Commenting on his appointment, Speers said: "Despite the tremendous advances in research and development we continue to face considerable market access challenges in the UK with uptake of innovative medicines still lagging significantly behind Europe.

"I am delighted to have been elected to lead the EMG and to continue the work we have undertaken to ensure that all UK citizens have timely access to appropriate, innovative medicines taking other countries in Europe as our benchmark."

Speers succeeds Nigel Brooksby (sanofi-aventis) who led the group for two years.

25th August 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics